ArticlePLoS computational biology2025
D3Impute: Dropout-aware discrimination, distribution-aware modeling, and density-guide imputation for scRNA-seq data.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of cellular heterogeneity. A major challenge, however, lies in the prevalence of non-biological zeros-false measurements caused by technical limitations that mask a cell's true transcriptome. This fundamental issue of distinguishing these artifacts from true biological zeros, where a gene is genuinely absent, remains a key hurdle for computational methods, as misclassification can distort biological signals during data recovery. To overcome this, we introduce D3Impute, a discriminative imputation framework built on three key innovations: (1) a distribution-aware normalization step that adapts to dataset-specific characteristics while preserving meaningful biological variation; (2) a dual-network discriminator that uses bulk RNA-seq data as a biological reference to accurately identify non-biological zeros while retaining the true biological zeros; and (3) a density-guided imputation engine that recovers expression values while maintaining local cellular neighborhood structures. Through comprehensive benchmarking against 12 state-of-the-art methods across six diverse datasets, D3Impute demonstrates consistent and significant improvements in essential downstream analyses, including cell clustering, trajectory inference, and differential expression detection. Furthermore, we provide an extensive practical evaluation of D3Impute, demonstrating its robustness across varying data qualities and providing clear guidelines for optimal application. By offering a robust, biologically informed, and user-oriented solution, D3Impute not only enhances scRNA-seq data analysis but also offers a generalizable framework for handling zero-inflated data in computational biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.